AAV Contract Manufacturing Market
完整報告名稱與涵蓋範圍
AAV Contract Manufacturing Market Size, Share & Trends Analysis Report, By Service Type (Process Development, Plasmid and Cell Bank Manufacturing, GMP Vector Production, Fill-Finish and Analytical Testing), By Production Platform (Transient Transfection (HEK293), Producer and Stable Cell Lines, Baculovirus-Insect Cell Systems), By Scale (Preclinical and Clinical, Commercial), By Therapeutic Area, By Region, and Segment Forecasts, 2026-2035
報告摘要
The AAV contract manufacturing market covers outsourced process development and GMP production of adeno-associated virus vectors for gene therapy, including plasmid and cell bank supply, upstream and downstream manufacturing, fill-finish and analytical release testing. Lentiviral and other vector types, and captive manufacturing by gene therapy companies, are excluded.
Demand is anchored by approved AAV therapies for neuromuscular, hematologic and retinal diseases and by a broad pipeline in which most sponsors depend on external capacity for at least part of their supply. The economics of AAV remain difficult: yields per litre are low, full-capsid ratios vary, and doses for systemic indications can exceed 10^14 vector genomes per kilogram, so improvements in suspension processes, producer cell lines, affinity purification and analytics have direct commercial consequences. After a period of overcapacity and program terminations, the market has rebalanced toward providers with proven commercial track records, integrated plasmid supply and flexible smaller-batch offerings for rare-disease programs.
North America and Europe dominate both sponsor demand and manufacturing capacity, with China and South Korea expanding rapidly through domestic pipelines and new campuses. Competition spans large integrated CDMOs, dedicated viral vector specialists and pharmaceutical groups offering excess capacity.
The InsightAce study supplies US$ forecasts for all service type, production platform, scale and therapeutic area and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AAV Contract Manufacturing Market Snapshot
Chapter 4. Global AAV Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Process Development
5.2.2. Plasmid and Cell Bank Manufacturing
5.2.3. GMP Vector Production
5.2.4. Fill-Finish and Analytical Testing
Chapter 6. Market Segmentation 2: By Production Platform Estimates & Trend Analysis
6.1. Production Platform & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Production Platform:
6.2.1. Transient Transfection (HEK293)
6.2.2. Producer and Stable Cell Lines
6.2.3. Baculovirus-Insect Cell Systems
Chapter 7. Market Segmentation 3: By Scale Estimates & Trend Analysis
7.1. Scale & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Scale:
7.2.1. Preclinical and Clinical
7.2.2. Commercial
Chapter 8. Market Segmentation 4: By Therapeutic Area Estimates & Trend Analysis
8.1. Therapeutic Area & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapeutic Area:
8.2.1. Neuromuscular and CNS Disorders
8.2.2. Ophthalmology
8.2.3. Hematology and Metabolic Disorders
8.2.4. Cardiovascular and Other Areas
Chapter 9. AAV Contract Manufacturing Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Novo Nordisk A/S (Catalent)
11.2. Thermo Fisher Scientific Inc.
11.3. Lonza Group AG
11.4. AGC Biologics
11.5. Oxford Biomedica plc
11.6. Andelyn Biosciences, Inc.
11.7. Charles River Laboratories International, Inc.
11.8. Genezen Laboratories, Inc.
11.9. Forge Biologics (Ajinomoto)
11.10. WuXi Advanced Therapies
11.11. Samsung Biologics Co., Ltd.
11.12. Viralgen (Bayer)
11.13. Yposkesi (SK pharmteco)
11.14. Aldevron (Danaher)
11.15. Rentschler Biopharma SE
圖表清單 List of Tables & Figures
Table 1. Global AAV Contract Manufacturing Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global AAV Contract Manufacturing Market Segmentation and Scope Overview
Table 2. Global AAV Contract Manufacturing Market Revenue Forecast by Production Platform, 2026-2035 (US$ Mn)
Figure 2. Global AAV Contract Manufacturing Market Share by Service Type, 2026 & 2035
Table 3. Global AAV Contract Manufacturing Market Revenue Forecast by Scale, 2026-2035 (US$ Mn)
Figure 3. AAV Manufacturing Cost Drivers: Yield, Full-Capsid Ratio and Dose Requirements
Table 4. Global AAV Contract Manufacturing Market Revenue Forecast by Therapeutic Area, 2026-2035 (US$ Mn)
Figure 4. Global AAV Vector Manufacturing Capacity Utilisation and Rebalancing, 2023-2028
Table 5. Global AAV Contract Manufacturing Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific AAV Contract Manufacturing Growth Opportunity Analysis
Table 6. North America AAV Contract Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key AAV Contract Manufacturing Market Participants
Table 7. Europe AAV Contract Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global AAV Contract Manufacturing Market
Table 8. Asia Pacific AAV Contract Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Production Platform Comparison: Transient Transfection, Stable Cell Lines and Baculovirus
Table 9. Strategic Developments of Leading AAV Contract Manufacturing Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們